- Home
- XNCR vs SAFE Comparison
XNCR vs SAFE Comparison
Compare XNCR & SAFE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XNCR
- SAFE
- Stock Information
- Founded
- XNCR 1997
- SAFE 2016
- Country
- XNCR United States
- SAFE United States
- Employees
- XNCR N/A
- SAFE N/A
- Industry
- XNCR Biotechnology: Pharmaceutical Preparations
- SAFE Real Estate Investment Trusts
- Sector
- XNCR Health Care
- SAFE Real Estate
- Exchange
- XNCR Nasdaq
- SAFE Nasdaq
- Market Cap
- XNCR 1.5B
- SAFE 1.8B
- IPO Year
- XNCR 2013
- SAFE 2017
- Fundamental
- Price
- XNCR $21.36
- SAFE $24.56
- Analyst Decision
- XNCR Strong Buy
- SAFE Buy
- Analyst Count
- XNCR 9
- SAFE 9
- Target Price
- XNCR $35.00
- SAFE $28.56
- AVG Volume (30 Days)
- XNCR 455.5K
- SAFE 384.5K
- Earning Date
- XNCR 11-05-2024
- SAFE 10-29-2024
- Dividend Yield
- XNCR N/A
- SAFE 2.88%
- EPS Growth
- XNCR N/A
- SAFE N/A
- EPS
- XNCR N/A
- SAFE N/A
- Revenue
- XNCR $133,618,000.00
- SAFE $400,237,000.00
- Revenue This Year
- XNCR N/A
- SAFE N/A
- Revenue Next Year
- XNCR $63.76
- SAFE $6.49
- P/E Ratio
- XNCR N/A
- SAFE N/A
- Revenue Growth
- XNCR 17.84
- SAFE 24.05
- 52 Week Low
- XNCR $15.31
- SAFE $15.00
- 52 Week High
- XNCR $26.84
- SAFE $28.80
- Technical
- Relative Strength Index (RSI)
- XNCR 62.14
- SAFE 42.08
- Support Level
- XNCR $20.70
- SAFE $24.30
- Resistance Level
- XNCR $21.88
- SAFE $25.36
- Average True Range (ATR)
- XNCR 0.74
- SAFE 0.57
- MACD
- XNCR 0.10
- SAFE -0.15
- Stochastic Oscillator
- XNCR 81.49
- SAFE 16.43
About XNCR Xencor Inc.
Xencor Inc is a clinical-stage biopharmaceutical company based in the United States. It focuses on discovering and developing engineered monoclonal antibody and other protein therapeutics to treat severe and life-threatening diseases such with unmet medical needs. The company uses its XmAb technology platform to create antibody product candidates such as XmAb5871 and XmAb7195. It also has a few pre-clinical stage candidates in its portfolio such as XmAb14045, XmAb662 among others. It earns its revenue from research and development collaborations and licenses of its internally developed drug candidates.
About SAFE Safehold Inc. New
Safehold Inc is a REIT that operates its business by acquiring, managing and capitalizing ground leases. Ground leases are long-term contracts between the landlord (the Company) and a tenant or leaseholder. Ground leases generally represent ownership of the land underlying commercial real estate projects that is net leased by the fee owner of the land to the owners/operators of the real estate projects built thereon.